<DOC>
	<DOCNO>NCT01389544</DOCNO>
	<brief_summary>This multicenter , open-label study assess effect multiple dose danoprevir/ritonavir steady-state pharmacokinetics methadone . Subjects stable methadone maintenance therapy ( 20 - 120 mg daily single oral morning dose ) receive danoprevir 100 mg orally twice daily ritonavir 100 mg orally twice daily 10 day .</brief_summary>
	<brief_title>A Study Interaction Between Danoprevir/Ritonavir Methadone</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lactams</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>Male female adult , 18 65 year age , inclusive Subjects must stable methadone maintenance regimen ( 20 120 mg/day ) treatment opiate addiction least 30 day prior screen stable dose least 14 day prior Day 1 Body weight &gt; /= 50 kg Body mass index ( BMI ) 18.0 32.0 kg/m2 Females childbearing potential male female partner childbearing potential must agree use 2 form nonhormonal contraception study 90 day last study drug administration Pregnant lactate woman male partner woman pregnant lactate Symptoms methadone withdrawal screening , Day 2 Day 1 Inadequate venous access History evidence clinically significant disease disorder , except drug abuse dependence Positive test alcohol drug abuse screen Day 2 ( exception methadone ) History ( within 3 month screen ) alcohol consumption exceed 2 standard drink per day average ( 1 standard drink = 10 gram alcohol ) ; alcohol consumption prohibit study confinement least 48 hour screen , dose schedule visit Positive hepatitis B , hepatitis C HIV infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>